Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Manipal Health Enterprises Limited (NSE: MANIPALHOS), ISIN INE459N01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MANIPALHOS last traded at ₹672.40 (+3.97%), with a 52-week range of ₹597.00 to ₹815.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 72.08%, FIIs 3.51%, DIIs 6.97%, mutual funds 4.63%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.